Jump to content

Fosdevirine

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Edgar181 (talk | contribs) at 22:23, 14 August 2018 (Fosdevirine is an experimental antiviral agent for potential use in the treatment of HIV-AIDS...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Fosdevirine
Clinical data
Other namesGSK2248761; GSK2248761A; IDX-12899; IDX-899
ATC code
  • None
Identifiers
  • 5-Chloro-3-[[3-[(E)-2-cyanoethenyl]-5-methylphenyl]-methoxyphosphoryl]-1H-indole-2-carboxamide
CAS Number
PubChem CID
Chemical and physical data
FormulaC20H17ClN3O3P
Molar mass413.80 g·mol−1
3D model (JSmol)
  • CC1=CC(=CC(=C1)/C=C/C#N)[P@](=O)(C2=C(NC3=C2C=C(C=C3)Cl)C(=O)N)OC
  • InChI=1S/C20H17ClN3O3P/c1-12-8-13(4-3-7-22)10-15(9-12)28(26,27-2)19-16-11-14(21)5-6-17(16)24-18(19)20(23)25/h3-6,8-11,24H,1-2H3,(H2,23,25)/b4-3+/t28-/m1/s1
  • Key:CGBYTKOSZYQOPV-ASSBYYIWSA-N

Fosdevirine is an experimental antiviral agent of the non-nucleoside reverse transcriptase inhibitor class that was studied for potential use in the treatment of HIV-AIDS.[1][2]

It was discovered by Idenix Pharmaceuticals and was being developed by GlaxoSmithKline and ViiV Healthcare, but it has now been discontinued[3][4] due to unexpected side effects.[5]

References

  1. ^ . PMID 26804933. {{cite journal}}: Cite journal requires |journal= (help); Missing or empty |title= (help)
  2. ^ "Fosdevirine". aidsinfo.nih.gov.
  3. ^ "Fosdevirine". Adis Insight. Highest Development Phases: Discontinued, HIV-1 infections
  4. ^ "Fosdevirine". MedKoo Biosciences. GSK2248761 is no longer in clinical development.
  5. ^ . doi:0.3851/IMP2689. {{cite journal}}: Check |doi= value (help); Cite journal requires |journal= (help); Missing or empty |title= (help)